The 26 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 182.50, with a high estimate of 291.00 and a low estimate of 125.00. The median estimate represents a +34.78% increase from the last price of 135.41.
The current consensus among 30 polled investment analysts is to Buy stock in Teladoc Health Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.67
Reporting Date Oct 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.